1.3.3 Others
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Profile
2.1.2 Erythropoietin Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Amgen Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Amgen News
2.2 Johnson & Johnson
2.2.1 Profile
2.2.2 Erythropoietin Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Johnson & Johnson Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share
(2016-2017)
2.2.4 Business Overview
2.2.5 Johnson & Johnson News
2.3 Roche
2.3.1 Profile
2.3.2 Erythropoietin Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Roche Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Roche News
2.4 Galenica
2.4.1 Profile
2.4.2 Erythropoietin Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Galenica Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Galenica News
2.5 Emcure
2.5.1 Profile
2.5.2 Erythropoietin Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Emcure Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview